ACH
CNMD icon

ArrowMark Colorado Holdings’s CONMED CNMD Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-454,572
Closed -$27.5M – 306
2025
Q1 		$27.5M Sell
454,572
-40,325
-8% -$2.6M 0.44% 70
2024
Q4 		$33.9M Sell
494,897
-6,906
-1% -$481K 0.46% 68
2024
Q3 		$36.1M Buy
501,803
+4,032
+0.8% +$285K 0.46% 63
2024
Q2 		$34.5M Buy
+497,771
New +$36.3M 0.41% 68

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

ArrowMark Colorado Holdings's CNMD Position: Q2 2025 in Review

ArrowMark Colorado Holdings sold out of CONMED (CNMD) in Q2 2025, closing a stake of 454,572 shares — an estimated $27.5M sold.

ArrowMark Colorado Holdings first reported a position in CNMD in Q2 2024 and held it in 4 quarters. The position peaked at $36.1M in Q3 2024. 277 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • ArrowMark Colorado Holdings reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 454,572 CONMED shares in Q2 2025, an estimated $27.5M.
  • ArrowMark Colorado Holdings first reported a position in CONMED in Q2 2024 and held it in 4 quarters.
  • ArrowMark Colorado Holdings's CONMED position peaked at $36.1M in Q3 2024.
  • 277 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.